- £14.09m
- £10.18m
- 22
- 11
- 36
- 11
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 10.3 | 2.22 | 0.699 | 0.359 | 0.905 |
Operating Profit | -10.3 | -2.22 | -0.699 | -0.359 | -0.905 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -10.3 | -2.21 | -0.698 | -0.359 | -0.788 |
Provision for Income Taxes | |||||
Net Income After Taxes | -10.3 | -2.21 | -0.698 | -0.359 | -0.788 |
Net Income Before Extraordinary Items | |||||
Net Income | -10.3 | -2.21 | -0.698 | -0.359 | -0.788 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -10.3 | -2.21 | -0.698 | -0.359 | -0.788 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.024 | -0.006 | -0.001 | -0.001 | -0.001 |